文献速递系统性红斑狼疮其他结缔组织病

系统性红斑狼疮中抗磷脂抗体与弥漫性肺泡出血风险的关联:系统综述与荟萃分析

Association between antiphospholipid antibodies and diffuse alveolar haemorrhage risk in systemic lupus erythematosus: a systematic review and meta-analysis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该系统综述与荟萃分析纳入9项研究共7746例系统性红斑狼疮患者,其中2016例(26.0%)抗磷脂抗体阳性、163例(2.1%)发生弥漫性肺泡出血。抗磷脂抗体阳性患者发生弥漫性肺泡出血的风险高于阴性患者(OR=1.76,95%CI 1.24-2.49;I²=0%),狼疮抗凝物阳性和抗心磷脂IgG阳性亦与风险升高相关,抗β2糖蛋白I IgG阳性则无显著关联。

要点

  • 系统性红斑狼疮患者中抗磷脂抗体(任何)阳性者发生弥漫性肺泡出血的风险高于阴性者(OR=1.76,95%CI 1.24-2.49;I²=0%)。
  • 狼疮抗凝物阳性(OR=1.76,95%CI 1.06-2.93;I²=35%)和抗心磷脂IgG阳性(OR=1.62,95%CI 1.13-2.34;I²=0%)与弥漫性肺泡出血风险升高相关。
  • 抗磷脂综合征诊断者发生弥漫性肺泡出血的可能性约为无抗磷脂综合征者的2.5倍(OR=2.46,95%CI 1.23-4.92;I²=0%)。

核心结论

  • 在系统性红斑狼疮患者中,抗磷脂抗体阳性者发生弥漫性肺泡出血的风险高于抗磷脂抗体阴性者,尤其是狼疮抗凝物阳性和抗心磷脂IgG阳性者。

研究设计与样本

  • 系统综述与荟萃分析,检索多个数据库自建库至2024年2月,纳入报告系统性红斑狼疮患者抗磷脂抗体状态与弥漫性肺泡出血结局的研究,采用固定效应模型合并比值比(OR)。
  • 共筛选454项研究,最终9项纳入荟萃分析,涵盖7746例系统性红斑狼疮患者,其中2016例(26.0%)抗磷脂抗体阳性,163例(2.1%)发生弥漫性肺泡出血。

主要发现

  • 系统性红斑狼疮患者中抗磷脂抗体(任何)阳性者发生弥漫性肺泡出血的风险高于抗磷脂抗体阴性者(OR=1.76,95%CI 1.24-2.49;I²=0%)。
  • 狼疮抗凝物阳性的系统性红斑狼疮患者发生弥漫性肺泡出血的风险高于狼疮抗凝物阴性者(OR=1.76,95%CI 1.06-2.93;I²=35%)。
  • 抗心磷脂IgG阳性的系统性红斑狼疮患者发生弥漫性肺泡出血的风险高于抗心磷脂IgG阴性者(OR=1.62,95%CI 1.13-2.34;I²=0%)。
  • 抗磷脂综合征诊断者发生弥漫性肺泡出血的可能性约为无抗磷脂综合征者的2.5倍(OR=2.46,95%CI 1.23-4.92;I²=0%)。
  • 抗β2糖蛋白I IgG阳性与系统性红斑狼疮患者发生弥漫性肺泡出血无显著关联(OR=0.78,95%CI 0.45-1.36;I²=0%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the association of aPL and diffuse alveolar haemorrhage (DAH) in patients with SLE by performing a systematic review and meta-analysis. METHODS: Multiple databases were systematically searched from inception to February 2024. Studies were eligible if they included patients with SLE (population), reported aPL status (exposure), and DAH (outcome). We pooled the estimates as odds ratio (OR) using fixed-effect models. We examined the association between aPL and DAH, as well as associations based on aPL subtypes or concomitant APS. RESULTS: Out of 454 screened studies, nine were included in meta-analysis, encompassing 7746 patients with SLE, of whom 2016 (26.0%) were aPL-positive and 163 (2.1%) had DAH. Patients with SLE and positive aPL (any) were more likely to develop DAH than aPL-negative patients (OR = 1.76, 95% CI 1.24-2.49; I2 = 0%). Patients with SLE and positive LA (OR = 1.76, 95% CI 1.06-2.93, I2 = 35%) or positive anticardiolipin IgG (OR = 1.62, 95% CI 1.13-2.34, I2 = 0%) had a higher likelihood of developing DAH compared with patients that were negative for these aPL. An APS diagnosis was associated with a 2.5-fold increased likelihood of DAH compared with subjects without APS (OR = 2.46, 95% CI 1.23-4.92, I2 = 0%). Positivity of anti-β2 glycoprotein I IgG was not significantly associated with DAH among patients with SLE (OR = 0.78, 95% CI 0.45-1.36, I2 = 0%). CONCLUSION: In patients with SLE, aPL positivity increases the risk of DAH compared with aPL-negative patients, particularly in those positive for LA and anticardiolipin IgG.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. González-Treviño M, Figueroa-Parra G, Yang JX, et al. Association between antiphospholipid antibodies and diffuse alveolar haemorrhage risk in systemic lupus erythematosus: a systematic review and meta-analysis. Rheumatology (Oxford). 2025. PMID: 39558618. doi:10.1093/rheumatology/keae632

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。